cardiovascular cancer News
-
Visit Aktiedagen Lund September 26, and learn how ultrasound can be used to fight the world’s deadliest diseases
At Aktiedagen Lund on Monday 26 September 2022, AcouSort’s Commercial Director Agnes Michanek will talk about how AcouSort’s unique and validated ultrasound technology can be used in the fight against cardiovascular diseases, infections, and cancer – the three deadliest diseases in the world. AcouSort is at a very exciting stage in the company’s development with a growing ...
By AcouSort AB
-
Sodexo health and wellness: embracing meatless mondays
Sodexo Blog - Health & Wellness by Chris Elam Here at Meatless Monday, we’re delighted that Sodexo is embracing the Meatless Monday movement in your client facilities around the country. We’re particularly pleased that you’ve chosen to focus on the health & wellness benefits, in line with your Better Tomorrow Plan, because it’s holistic changes which can improve ...
By 3BL Media
-
Why we need to drink hydrogen water and where can i buy hydrogen water
Olansi Healthcare Co., Ltd(Guangzhou Olans Water Treatment Equipments Co. Ltd) is a professional manufacturer in producing hydrogen water products,including hydrogen water maker,hydrogen water machine,hydrogen water filter,hydrogen water generators and hydrogen water bottle.hydrogen water makerIn our life,many people now more focus on their health.like water,many people choose hydrogen water.Does ...
-
Regeneron to Report First Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2022
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2022 financial and operating results on Wednesday, May 4, 2022, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information Participants may access the conference call live via webcast on ...
-
Why we need to drink hydrogen water and where can i buy hydrogen water
Olansi Healthcare Co., Ltd(Guangzhou Olans Water Treatment Equipments Co. Ltd) is a professional manufacturer in producing hydrogen water products,including hydrogen water maker,hydrogen water machine,hydrogen water filter,hydrogen water generators and hydrogen water bottle. hydrogen water maker In our life,many people now more focus on their health.like water,many people choose hydrogen ...
-
University of Louisville to host community forum on social and environmental determinants of health
The University of Louisville Center for Environmental Genomics and Integrative Biology (CEGIB) will host a community forum on the social and environmental determinants of health on Wednesday, Oct. 20, 4:30 p.m., at The Nia Center, 2900 W. Broadway. Linda Birnbaum, Ph.D., director of the National Institute of Environmental Health Sciences (NIEHS) and the National Toxicology Program (NTP), will ...
-
BOC Sciences Outlines Its Contribution of Peptides to Cardiovascular Research
BOC Sciences' monthly report released in August showed that its peptide products had vastly facilitated the R&D of cardiovascular therapies. February is set as American Heart Month since heart disease is the number one cause of death for most groups, affecting all ages, genders, and races. More than 600,000 Americans die from heart disease every year. The striking fact drives a great deal ...
By BOC Sciences
-
EU project shows eating right does the body good
Fruits, vegetables and nuts are just some of the foods that form part of a group of antioxidant chemical compounds called flavonoids. There is growing evidence that flavonoids, part of the polyphenols group, keeps humans healthy, fighting off cardiovascular disease, cancer and degenerative diseases. FLORA, a EUR 3.3 million EU-funded project, is helping people understand the link between diet and ...
-
BOC Sciences: Peptides Open New Path toward Osteoporosis Treatment
BOC Sciences declares that some of its peptide products have been proven applicable for osteoporosis treatment, which is a significant contribution to the therapeutic areas. Bone tissue engineering and the research surrounding peptides have expanded significantly over the last few decades. Several peptides have been shown to support and stimulate the bone healing response and have been proposed ...
By BOC Sciences
-
Agilent Technologies Completes Acquisition of Seahorse Bioscience, Industry Leader in Tools for Measuring Cell Metabolism
Agilent Technologies Inc. today announced it has completed the acquisition of Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics. Agilent announced its intent to acquire Seahorse on Sept. 9. Seahorse's leading technology enables researchers to better understand cell health, function and signaling, and how the cell may be impacted ...
-
Gesynta Pharma reports positive Phase I results with lead candidate GS-248 for microvascular disease at EULAR 2020
Gesynta Pharma AB ("Gesynta"), a clinical stage company developing novel anti-inflammatory agents, today announced that the results from the successfully completed First-in-Human clinical study with its lead candidate GS-248 for the treatment of microvascular disease have been presented at the EULAR 2020 E-Congress. Following these results, Gesynta now intends to commence a Phase II study in ...
-
Gesynta Pharma initiates clinical phase I study with GS-248 for the treatment of microvascular disease
Gesynta Pharma AB ("Gesynta") announces that the first clinical study with GS-248 has been initiated and that the first healthy volunteers have been dosed. The purpose of the phase I study is to study safety, tolerability and pharmacokinetic properties of GS-248 as well as its effect on relevant biomarkers. Gesynta's lead candidate drug, GS-248, is a potent and selective inhibitor of ...
-
Agilent Technologies to Acquire Seahorse Bioscience, Industry Leader in Tools for Measuring Cell Metabolism
Agilent Technologies Inc. (NYSE: A) and Seahorse Bioscience today announced they have signed a definitive agreement under which Agilent will acquire Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics. Exploration into cell metabolism is rapidly accelerating as the links between mitochondrial function and disease are increasingly ...
-
Creative Proteomics Unleashes the Exosome Untargeted Metabolomics Service
Creative Proteomics, the globally recognized proteomics, metabolomics, and multi-omics service provider, is delighted to introduce its exosome untargeted metabolomics services—a premier-stage offering in their broad catalogue services. Exosomes are tiny extracellular vesicles, hosting a diverse array of molecules including proteins, RNAs, and metabolites. With a diameter ranging between ...
-
Agilent Technologies Launches Updated Gene Expression Microarrays for Human, Mouse and Rat Models
Agilent Technologies Inc. (NYSE: A) today announced updates to its SurePrint gene expression microarrays for messenger RNA profiling applications for human, mouse and rat models. The updates improve coding and noncoding content, which will provide up-to-date tools for researchers to investigate expression patterns on a highly accessible platform. Agilent developed the updates to its flagship ...
-
Gesynta Pharma announces positive Phase I results with GS-248 for the treatment of microvascular disease - data to be presented at EULAR congress
Gesynta Pharma AB ("Gesynta") announces the completion and positive results of a first clinical study with GS-248. The purpose of the study was to evaluate safety, tolerability, pharmacokinetic and pharmacodynamic properties of GS-248 after single and multiple ascending doses to healthy subjects. The results support the further clinical development of GS-248 in microvascular dysfunction and a ...
-
Dorian Therapeutics Accesses Novel Compound Library from Ubiquigent
Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system-focused drug discovery, announced today that it had entered into an agreement with Dorian Therapeutics to provide access to one of its novel small molecule libraries specifically designed to target deubiquitylase (DUB) enzymes. “We hope that this is just the beginning of a fruitful partnership, and that ...
-
Omega Medical Imaging Announces Installation of First AI Image-Guided Interventional Endoscopy System in Hawai’i
Sanford, Florida (July 28, 2021) — Omega Medical Imaging, the leading innovator in AI image-guided interventional systems for hospitals and healthcare facilities around the world, announced the installation of the E-View.AI interventional endoscopy system at the Pali Momi Medical Center in Hawai’i. The E-View.AI represents the first AI image-guided system in the state of ...
-
Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant
Creative Enzymes, a global leader in enzyme production, is thrilled to announce the latest addition to their hydrolase product line, the Recombinant S-Adenosyl-L-Homocysteine Hydrolase (SAHH). This announcement underscores its unwavering commitment to enzyme innovation and proven track to offering scientifically advanced products. SAHH, a crucial enzyme involved in the biological methylation ...
-
Creative Proteomics Introduces Methionine Cycle Analysis Service for Metabolomics Research
Creative Proteomics, a leading provider of advanced proteomics and metabolomics services, is proud to announce the launch of its innovative Methionine Cycle Analysis Service. This service represents a significant leap forward in the field of metabolomics, providing researchers with a powerful tool to unravel the complexities of metabolic pathways. Methionine, a pivotal amino acid, is central to ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you